LLY.BA Eli Lilly and Company
P/E
0.18389522
Forward P/E
--
Price/Sales
91.335335
Beta
0.517
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Eli Lilly and Company is trading 2.03% up today after announcing a neurodegeneration partnership and Q3 dividend
Eli Lilly and Company is trading 2.03% up at $30,200.00, following significant company-specific developments. • The company announced a strategic collaboration...
🔴 Eli Lilly and Company is trading 2.8% down today as profit-taking extends multi-day slide
Eli Lilly and Company is trading 2.8% down at $28,780.00, extending a multi-day slide from $30,340.00 on June 15 as investors lock in recent gains. • No fresh...
Eli Lilly Jaypirca Cuts Leukemia Progression Risk 45%, Beating Standard Care
Eli Lilly announced positive results from its Phase 3 BRUIN CLL-322 trial for Jaypirca (pirtobrutinib). Adding Jaypirca to a standard treatment of venetoclax...
Lilly Advances AJX-101, Showing Success in Treatment-Resistant Myelofibrosis Patients
Eli Lilly and Company reported Phase 1 data for its investigational type II JAK2 inhibitor at the 2026 European Hematology Association (EHA) Annual Meeting....